Emodepside, a cyclo-octadepsipeptide anthelmintic with a novel mode of action

Drugs of the Future

Volumn 29, Issue 10, 2004, Pages 1015-1024

  Amliwala, Kiran ^a   Bull, Kathryn ^a   Willson, James ^a   Harder, Achim ^b   Holden Dye, Lindy ^a   Walker, Robert J ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; ALPHA LATROTOXIN; ANTHELMINTIC AGENT; ANTIPODE; BACLOFEN; BAY 444400; BEAUVERICIN; BICUCULLINE; BISPARAMORPHONYL DERIVATIVE; CYCLO(DEXTRO LACTYL N METHYLLEUCYL DEXTRO 3 PHENYLLACTYL N METHYLLEUCYL DEXTRO LACTYL N METHYLLEUCYL DEXTRO 3 PHENYLLACTYL N METHYLLEUCYL); CYCLOOCTADEPSIPEPTIDE; DIACYLGLYCEROL; DRUG RECEPTOR; EMODEPSIDE; ENNIATIN; GUANINE NUCLEOTIDE BINDING PROTEIN; LATROPHILIN RECEPTOR; LATROPHILIN RECEPTOR 1; LATROPHILIN RECEPTOR 2; LEVAMISOLE; LYSOPHOSPHOLIPASE; NEUROTRANSMITTER RECEPTOR; PF 1022001; PF 1022221; PIPERAZINE; PROTEIN B0286 2; PROTEIN B0457 1; PYRANTEL; UNCLASSIFIED DRUG; VALINOMYCIN;

ANTHELMINTIC ACTIVITY; ASCARIS SUUM; CAENORHABDITIS ELEGANS; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; DRUG ISOLATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; ENZYME ACTIVATION; GABAERGIC TRANSMISSION; IC 50; MUSCLE CONTRACTION; NEMATODE; NEUROTRANSMITTER RELEASE; NONHUMAN; PATENT; REVIEW; RNA INTERFERENCE; SKELETAL MUSCLE;

EID: 11144225918     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2004.029.10.863392     Document Type: Review

References (85)

1. Lacey, E. Mode of action of benzimidazoles. Parasitol Today 1990, 6:112-5.
2. Conder, G.A. Chemical control of animal-parasitic nematodes. In: The Biology of Nematodes. D.L. Lee (Ed.). Taylor and Francis, London, 2002, 521-9.
3. Harrow, I.D., Oration, K.A.F. Mode of action of anthelmintics morantel, pyrantel and levamisole on the muscle cell membrane of the nematode, Ascaris suum. Pestic Sci 1985, 16: 662-72.
4. Brownlee, D.J.A., Holden-Dye, L., Walker, R.J. Actions of the anthelmintic ivermectin on the pharyngeal muscle of the parasitic nematode, Ascaris suum. Parasitology 1997, 115: 553-61.
5. Cully, D.F., Vassilatis, D.K., Liu, K.K., Paress, P.S., Van der Ploeg, L.H.T., Schaeffer, J.M. Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans. Nature 1994, 371:707-11.
6. Pemberton, D.J., Franks, C.J., Walker, R.J., Holden-Dye, L. Characterization of glutamate-gated chloride channels in the pharynx of wild-type and mutant Caenorhabditis elegans delineates the role of the subunit GluCl-alpha in the function of the native receptor. Mol Pharmacol 2001, 59: 1037-43.
7. Bascal, Z.A., Cunningham, J.M., Holden-Dye, L., O'Shea, M., Walker, R.J. Characterization of a putative nitric oxide synthase in the neuromuscular system of the parasitic nematode, Ascaris suum. Parasitology 2001, 122: 219-31.
8. Bascal, Z.A., Montgomery, A., Holden-Dye, L., Williams, R.G., Walker, R.J. Histochemical mapping of NADPH diaphorase in the nervous system of the parasitic nematode, Ascaris suum. Parasitology 1995, 110: 625-37.
9. Hamdan, F.F., Ungrin, M.D., Abramovitz, M., Ribeiro, P. Characterization of a novel serotonin receptor from Caenorhabditis elegans: Cloning and expression of two splice variants. J Neurochem 1999, 72: 1372-83.
10. Holden-Dye, L., Krogsgaard-Larsen, P., Nielsen, L., Walker, R.J. GABA receptors on the somatic muscle cells of the parasitic nematode, Ascaris suum: Stereoselectivity indicates similarity to a GABA-A-type agonist recognition site. Br J Pharmacol 1989, 98: 841-50.
11. Li, C., Nelson, L.S., Kim, K., Nathoo, A., Hart, A.C. Neuropeptide gene families in the nematode Caenorhabditis elegans. Ann NY Acad Sci 1999, 897: 239-52.
12. Olde, B., McCombie, W.R. Molecular cloning and functional expression of a serotonin receptor from Caenorhabditis elegans. J Mol Neurosci 1997, 8: 53-62.
13. Rogers, C.M., Franks, C.J., Walker, R.J., Burke, J.F., Holden-Dye, L. Regulation of the pharynx of Caenorhabditis elegans by 5-HT, octopamine and FMRFamide-like neuropeptides. J Neurobiol 2001, 49: 235-44.
14. Suo, S., Sasagawa, N., Ishiura, S. Identification of a dopamine receptor from Caenorhabditis elegans. Neurosci Lett 2002, 319: 13-6.
15. Trim, J.E., Holden-Dye, L., Willson, J., Lockyer, M., Walker, R.J. Characterization of 5-HT receptors in the parasitic nematode, Ascaris suum. Parasitology 2001, 122: 207-17.
16. Martin, R.J. Electrophysiological effects of piperazine and diethylcarbamazine on Ascaris suum somatic muscle. Br J Pharmacol 1982, 77: 255-65.
17. Del Castillo, J., Morales, T., Sanchez, V. Action of piperazine on the neuromuscular system of Ascaris lumbricoides. Nature 1963, 200: 706-7.
18. Rew, R.S., Fetterer, R.H. Mode of action of antinematodal drugs. In: Chemotherapy of Parasitic Diseases. W.C. Campbell, R.S. Rew (Eds.). Plenum Press, New York, 1986, 321-37.
19. Sangster, N.C., Dobson, R.J. Anthelmintic resistance. In: The Biology of Nematodes. D.L. Lee (Ed.). Taylor and Francis, London, 2002, 531-67.
20. Geary, T.G., Thompson, D.P. Development of antiparasitic drugs in the 21st century. Vet Parasitol 2003, 115: 167-84.
21. Kirst, H.A., Creemer, L.C., Naylor, S.A. et al. Evaluation and development of spinosyns to control ectoparasites on cattle and sheep. Curr Top Med Chem 2002, 2: 675-99.
22. Gilles, H.M., Hoffman, P.S. Treatment of intestinal parasitic infections: A review of nitazoxanide. Trends Parasitol 2002, 18: 95-7.
23. Meinke, P.T. Perspectives in animal health: Old targets and new opportunities. J Med Chem 2001, 44: 641-59.
24. Meinke, P.T., Smith, M.M., Snoop, W.L. Nodulisporic acid: Its chemistry and biology. Curr Top Med 2002, 2: 655-74.
25. Thompson, D.P., Klein, R.D., Geary, T.G. Prospects for rational approaches to anthelmintic discovery. Parasitology 1996, 113: S217-38.
26. Shoop, W.L., Egerton, J.R., Eary, C.H., Suhayda, D. Anthelmintic activity of paraherquamide in sheep. J Parasitol 1990, 76: 349-51.
27. Robertson, A.P., Clark, C.L., Burns, T. et al. Paraherquamide and 2-deoxy-paraherquamide distinguish cholinergic receptor subtypes in Ascaris muscle. J. Pharmacol Exp Ther 2002, 302: 853-60.
28. Zinser, E.W., Wolf, M.L., Alexander-Bowman, S.J. et al. Anthelmintic paraherquamides are cholinergic antagonists in gastrointestinal nematodes and mammals. J Vet Pharmacol Ther 2002, 25: 241-50.
29. Stepek, G., Behnke, J.M., Buttle, D.J., Duce, I.R. Natural plant cysteine proteinases as anthelmintics? Trends Parasitol 2004, 20: 322-7.
30. Martin, R.J. Modes of action of anthelmintic drugs. Vet J 1997, 154: 11-34.
31. Kim, K., Li, C. Expression and regulation of an FMRFamide-related neuropeptide gene family in Caenorhabditis elegans. J Comp Neurol 2004, 475: 540-50.
32. Nathoo, A.N., Moeller, R.A., Westlund, B.A., Hart, A.C. Identification of neuropeptide-like protein gene families in Caenorhabditis elegans and other species. Proc Natl Acad Sci USA 2001, 98: 14000-5.
33. Nelson, L.S., Kim, K., Memmott, J.E., Li, C. FMRFamide-related gene family in the nematode, Caenorhabditis elegans. Mol Brain Res 1998, 58: 103-11.
34. Bargmann, C.I. Neurobiology of the Caenorhabditis elegans genome. Science 1998, 282: 2028-33.
35. Salkoff, L., Butler, A., Fawcett, G. et al. Evolution tunes the excitability of individual neurons. Neuroscience 2001, 103: 853-9.
36. Wei, A., Jegla, T., Salkoff, L. Eight potassium channel families revealed by the C. elegans genome project. Neuropharmacology 1996, 35: 805-29.
37. Santi, C.M., Yuan, A., Fawcett, G. et al. Dissection of potassium currents in Caenorhabditis elegans muscle cells by genetics and RNA interference. Proc Natl Acad Sci USA 2003, 100: 14391-6.
38. Sangster, N.C. Pharmacology of anthelmintic resistance. Parasitology 1996, 113: 201-16.
39. Sangster, N.C., Gill, J. Pharmacology of anthelmintic resistance. Parasitol Today 1999, 15: 141-6.
40. Sangster, N.C., Davis, C.W., Collins, G.H. Effects of cholinergic drugs on longitudinal contraction in levamisole-susceptible and- resistant Haemonchus contortus. Int J Parasitol 1991, 21: 689-95.
41. Mejia, M.E., Fernandez Igartua, B.M., Schmidt, E.E., Cabaret, J. Multispecies and multiple anthelmintic resistance on cattle nematodes in a farm in Argentina: The beginning of high resistance? Vet Res 2003, 34: 461-7.
42. Sasaki, T., Takagi, T., Yaguchi, T., Mijadoh, S., Okasda, T., Koyama, M. A new anthelmintic cyclodepsipeptide, PF1022A. J Antibiot 1992, 45: 692-7.
43. Geßner, G., Meders, S., Rink, T., Harder, A. Ionophore and anthelmintic activity of PF1022A, a cyclooctadepsipeptide, are not related. Pestic Sci 1996, 48: 399-407.
44. Terada, M. Neuropharmacological mechanism of action of PF1022A, an antinematode anthelmintic with a new structure of cyclodepsipeptide, on Angiostrongylus cantonensis and isolated frog rectus. Jpn J Parasitol 1992, 32: 633-42.
45. Conder, G.A., Thompson, D.P., Johnson, S.S. Demonstration of co-resistance of Haemonchus contortus to ivermectin and moxidectin.Vet Rec 1993,132: 651-2.
46. Samson-Himmelstjerna, G., Harder, A., Schneider, T., Kalbe, J., Mencke, N. In vivo activities of the new anthelmintic depsipeptide PF1022A. Parasitol Rec 2000, 86: 194-9.
47. Harder, A., Schmitt-Wrede, H.P., Krucken, J. et al. Cyclooctadepsipeptides - An anthelmintically active class of compounds exhibiting a novel mode of action, Int J Antimicrob Agents 2003, 22: 318-31.
48. Yanai, K., Sumida, N., Okakura, K., Moriya, T., Watanabe, M., Murakami, T. Para-position derivatives of fungal anthelmintic cyclodepsipeptides engineered with Streptomyces venezuelae antibiotic biosynthetic genes. Nat Biotechnol 2004, 22: 848-55.
49. Johnson, C.D., Stretton, A.O.W. GABA-immunoreactivity in inhibitory motor neurons of the nematode, Ascaris. J Neurosci 1987, 7: 223-35.
50. Martin, R.J., Harder, A., Londershausen, M., Jeschke, P. Anthelmintic actions of the cyclic depsipeptide PF1022A and its electrophysiological effects on muscle cells of Ascaris suum. Pestic Sci 1996, 48: 343-9.
51. Chen, W., Terada, M., Cheng, J.T. Characterization of sub-types of gamma-aminobutyric acid receptors in an Ascaris muscle preparation by binding assay and binding of PF1022A, a new anthelmintic, on the receptors. Parasitol Res 1996, 82: 97-101.
52. Holden-Dye, L., Hewitt, G.M., Wann, K.T., Krogsgaard-Larsen, P., Walker, R.J. Studies involving avermectin and the 4-aminobutyric acid (GABA) receptor for Ascaris suum.Pestic Sci 1988, 24: 231-45.
53. Holden-Dye, L., Walker, R.J. Classical GABA and glycine receptor antagonists preferentially block the response to acetylcholine in the nematode Ascaris. Neurosci Lett 1990, Suppl 38: S113.
54. Walker, R.J., Colquhoun, L.M., Parri, H.R., Williams, R.G., Holden-Dye, L. Pharmacology of the Ascaris nervous system. In: Neurotox '91: Molecular Basis of Drug and Pesticide Action. I.R. Duce (Ed.). Elsevier Applied Science, London, 1992, 105-21.
55. Walker, R.J., Holden-Dye, L. Evolutionary aspects of transmitter molecules, their receptors and channels. Parasitology 1991, 102: S7-S29.
56. Nicolay, R, Harder, A., von Samson-Himmelstjerna, G., Mehlhorn, H. Synergistic action of a cyclic depsipeptide and piperazine on nematodes. Parasitol Res 2000, 86: 982-92.
57. Willson, J., Amliwala, K., Harder, A., Holden-Dye, L., Walker, R.J. The effect of the anthelmintic emodepside at the neuromuscular junction of the parasitic nematode, Ascaris suum. Parasitology 2003, 126: 79-86.
58. Johnson, C.D., Stretton, A.O.W. Localization of choline acetyltransferase within identified motoneurons of the nematode, Ascaris. J Neurosci 1985, 5: 1984-92.
59. Martin, R.J. The effect of γ-aminobutyric acid on the input conductance and membrane potential of Ascaris muscle. Br J Pharmacol 1980, 71: 99-106.
60. Cowden, C., Stretton, A.O.W. AF2, an Ascaris neuropeptide: Isolation, sequence and bioactivity. Peptides 1993, 14: 423-30.
61. Pang F.Y., Mason, J., Holden-Dye, L., Franks, C.J., Williams, R.G , Walker, R.J. The effect of the nematode peptide, KHEYLRFamide (AF2), on the somatic musculature of the parasitic nematode, Ascaris suum. Parasitology 1995, 110: 353-62.
62. Geary, T.G., Price, D.A., Bowman, J.W. et al. Two FMRFamide-like peptides from the free-living nematode, Panagrellus redivivus. Peptides 1992, 13: 209-14.
63. Franks, C.J., Holden-Dye, L., Williams, R.G., Pang, F.Y., Walker, R.J. A nematode FMRFamide-like peptide, SDPNFLRFamide, relaxes the dorsal muscle strip preparation of Ascaris suum. Parasitology 1994, 108: 229-36.
64. Franks, C.J., Walker, R.J., Holden-Dye, L. A structure-activity study of the neuropeptide PF1, SDPNFLRFamide, using the dorsal body wall muscle of the chicken nematode, Ascaridia galli. Acta Biol Hung 2004, 55: 343-51.
65. Holden-Dye, L., Franks, C.J., Williams, R.G., Walker, R.J. The effects of the nematode peptides SDPNFLRFamide (PF1) and SADPNFLRFamide (PF2) on synaptic transmission in the parasitic nematode, Ascaris suum. Parasitology 1995, 110: 449-55.
66. Walker, R.J., Franks, C.J., Pemberton, D., Rogers, C., Holden-Dye, L. Physiological and pharmacological studies on nematodes. Acta Biol Hung 2000, 51: 379-94.
67. Saeger, B., Schmitt-Wrede, H.P., Dehnhardt, M. et al. Latrophilin-like receptor from the parasitic nematode, Haemonchus contortus, as target for the anthelmintic depsipeptide, PF1022A. FASEB J 2001, 15: 1332-4.
68. Petrenko, A.G., Kovalenko, V.A., Shamotienko, O.G., Surkova, I.N., Tarasyuk, T.A., Ushkaryov, Y., Grishin, E.V. Isolation and properties of the α-latrotoxin receptor. EMBO J 1990, 9: 2023-7.
69. Willson, J., Amliwala, K., Davis, A. et al. Latrotoxin receptor signaling engages the UNC-13 dependent vesicle priming pathway in C. elegans. Curr Biol 2004, 14: 1374-9.
70. Betz, W.J., Mao, F., Bewick, G.S. Activity-dependent fluorescent staining and destaining of living vertebrate motor nerve terminals. J Neurosci 1992, 12: 363-75.
71. Cochilla, A.J., Angleson, U.K., Betz, W.J. Monitoring secretory membrane with FM1-43 fluorescence. Ann Rev Neurosci 1999, 22: 1-10.
72. Capogna, M., Gahwiler, B.H., Thompson, S.M., Calcium independent actions of alpha-latrotoxin on spontaneous and evoked synaptic transmission in the hippocampus. J Neurophysiol 1996, 76: 3149-58.
73. Longenecker, H.E. Jr., Hurlbut, W.P., Mauro, A., Clark, A.W. Effect of black widow spider venom on the frog neuromuscular junction. Effects on end-plate potential, miniature end-plate potential and nerve terminal spike. Nature 1979, 225: 701-3.
74. Rahman, M.A., Ashton, A.C., Meunier, E.A., Davletov, B.A., Dolly, J.O., Ushkaryov, Y.A. Norepinephrine exocytosis stimulated by α-latrotoxin requires both external and stored calcium and is mediated by latrophilin, G proteins and phospholipase C. Philos T Roy Soc B 1999, 354: 379-86.
75. Brundage, L., Avery, L., Katz, A., Kim, U.J., Mendel, J.E., Sternberg, P.W., Simon, M.I. Mutations in a C. elegans Gqα gene disrupt movement, egg laying, and viability. Neuron 1996, 16: 999-1009.
76. Lee, C.H., Park, D., Wu, D., Rhee, S.G., Simon, M.I. Members of the Gq α subunit gene family activate phospholipase C beta isozymes. J Biol Chem 1992, 267:16044-7.
77. Taylor, S.J., Exton, J.H., Two α subunits of the Gq class of G proteins stimulate phosphoinositide phospholipase C-β 1 activity. FEBS Lett 1991, 286: 214-6.
78. Miller, K.G., Emerson, M.D., Rand, J.B. Goα and diacylglycerol kinase negatively regulate the Gqα pathway in C. elegans. Neuron 1999, 24: 323-33.
79. Nurrish, S., Segalat, L., Kaplan, J.M. Serotonin inhibition of synaptic transmission: Gα(o) decreases the abundance of UNC-13 at release sites. Neuron 1999, 24: 231-42.
80. Lackner, M.R., Nurrish, S.J., Kaplan, J.M. Facilitation of synaptic transmission by EGL-30 Gqα and EGL-8 PLCβ: DAG binding to UNC-13 I required to stimulate acetylcholine release. Neuron 1999, 24: 353-46.
81. Ahmed, S., Maruyama, I.N., Kozma, R., Lee, J., Brenner, S., Lim, L. The Caenorhabditis elegans unc-13 gene product is a phospholipid-dependent high affinity phorbol ester receptor. Biochem J 1992, 287: 995-9.
82. Kazanietz, M.G., Lewin, N.E., Bruns, J.D., Blumberg, P.M. Characterization of the cysteine-rich region of the Caenorhabditis elegans protein UNC-13 as a high affinity phorbol ester receptor. Analysis of ligand-binding interactions, lipid cofactor requirements, and inhibitor sensitivity. J Biol Chem 1995, 270: 10777-83.
83. Richmond, J.E., Weimer, R.M., Jorgensen, E.M. An open form of syntaxin bypasses the requirement for UNC-13 in vesicle priming. Nature 2001, 412: 338-41.
84. Bennett, M.K., Calakos, N., Scheller, R.H. Syntaxin: A synaptic protein implicated in docking of synaptic vesicles at presynaptic active zones. Science 1992, 257: 255-9.
85. Soller, T., Bennett, M.K., Whiteheart, S.W., Scheller, R.H., Rothman, J.E. A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion. Cell 1993, 75: 409-18.